{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-002939","form_type":"8-K","ticker":"CGTX","cik":"0001455365","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.661973+00:00","generated_at":"2026-05-28T03:07:07.550423+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Cognition Therapeutics files investor presentation with no material updates disclosed","bullets":["Filed an investor presentation under Item 7.01 for Regulation FD purposes.","Presentation slide titled 'Targeting Pathogenic Oligomers: A Disruptive Approach to Neurodegenerative Diseases'.","No financial results, pipeline milestones, or guidance changes are included in the filing.","Filing is a routine disclosure; no new material events reported."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-002939","json":"https://secwatch.observer/filing/0001104659-25-002939.json","markdown":"https://secwatch.observer/filing/0001104659-25-002939.md","text":"https://secwatch.observer/filing/0001104659-25-002939.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465925002939/0001104659-25-002939-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465925002939/tm253137d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:07:07.550423+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}